The Gaucher disease treatment market is a specialized segment of the pharmaceutical industry, providing therapies for patients with Gaucher disease, a rare genetic disorder that affects the body's ability to break down certain fatty substances. With rising prevalence, improved diagnostics, and innovative treatments like enzyme replacement therapy (ERT), substrate reduction therapy (SRT), and...